Chemotherapy of head and neck cancer: Combination treatment with cyclophosphamide, adriamycin, methotrexate, and bleomycin

A combination of cyclophosphamide, adriamycin, methotrexate, and bleomycin (CAMB) was explored in patients with advanced, nonresectable epidermoid carcinoma from primary sites in the head and neck, recurrent or persistent after radiation or surgery. Objective regression (greater than 50%) of measura...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Medical and pediatric oncology 1977, Vol.3 (3), p.301-309
Hauptverfasser:	Wittes, Robert E., Spiro, Ronald H., Shah, Jatin, Gerold, Frank P., Koven, Bernard, Strong, Elliot W.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Bleomycin - administration & dosage Bleomycin - adverse effects Bleomycin - therapeutic use Carcinoma, Squamous Cell - drug therapy Carcinoma, Squamous Cell - mortality chemotherapy Cyclophosphamide - administration & dosage Cyclophosphamide - adverse effects Cyclophosphamide - therapeutic use Doxorubicin - administration & dosage Doxorubicin - adverse effects Doxorubicin - therapeutic use Drug Evaluation Drug Therapy, Combination epidermoid carcinoma Female head and neck cancer Head and Neck Neoplasms - drug therapy Head and Neck Neoplasms - mortality Humans Male Methotrexate - administration & dosage Methotrexate - adverse effects Methotrexate - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!